OTC Acetaminophen Label Guidance For Liver Warning Clarifies Ingredient Specifics

FDA allows marketers of acetaminophen-containing OTC products to use an alternative liver warning, according to an updated guidance. The change from the draft, which aligns with a request by CHPA, separates maximum dosage for the ingredient from the dosage included in a certain product.

More from United States

More from North America